![Brimonidine gel 0.33% rapidly improves patient‐reported outcomes by controlling facial erythema of rosacea: a randomized, double‐blind, vehicle‐controlled study - Layton - 2015 - Journal of the European Academy of Dermatology and Venereology - Brimonidine gel 0.33% rapidly improves patient‐reported outcomes by controlling facial erythema of rosacea: a randomized, double‐blind, vehicle‐controlled study - Layton - 2015 - Journal of the European Academy of Dermatology and Venereology -](https://onlinelibrary.wiley.com/cms/asset/e34cc4b0-996a-4c89-8154-7af47ccf2e7f/jdv13305-fig-0005-m.jpg)
Brimonidine gel 0.33% rapidly improves patient‐reported outcomes by controlling facial erythema of rosacea: a randomized, double‐blind, vehicle‐controlled study - Layton - 2015 - Journal of the European Academy of Dermatology and Venereology -
![Rosacea. Central facial erythema of rosacea at baseline was responsive... | Download Scientific Diagram Rosacea. Central facial erythema of rosacea at baseline was responsive... | Download Scientific Diagram](https://www.researchgate.net/publication/261756562/figure/fig1/AS:282637194285072@1444397366628/Rosacea-Central-facial-erythema-of-rosacea-at-baseline-was-responsive-to-topical.png)
Rosacea. Central facial erythema of rosacea at baseline was responsive... | Download Scientific Diagram
![Paradoxical Erythema Reaction of Long-term Topical Brimonidine Gel for the Treatment of Facial Erythema of Rosacea - JDDonline - Journal of Drugs in Dermatology Paradoxical Erythema Reaction of Long-term Topical Brimonidine Gel for the Treatment of Facial Erythema of Rosacea - JDDonline - Journal of Drugs in Dermatology](http://dl.jddonline.com/articleimages/article_3018/table1.png)